🇪🇬Egypt Planned
EPTTS (Egyptian Pharmaceutical Track & Trace System) Egyptian Drug AuthoritySerialization Requirements
| Level | Required | Identifier Type | Description |
|---|---|---|---|
| Unit | Required | SGTIN |
Unit-level serialization with 2D DataMatrix (GTIN, serial, batch, expiry) |
| Case/Bundle | Required | SSCC |
Aggregation at case level required |
| Pallet/Shipper | Required | SSCC |
Pallet level aggregation required |
Reporting Obligations
| Event Type | Required | Timing | Description |
|---|---|---|---|
| Commissioning | Required | Before distribution | Serial activation |
| Shipping | Required | At dispatch | Shipment notification |
| Receiving | Required | Upon receipt | Receipt confirmation |
| Authentication | Required | At verification points | Product verification |
Technical Requirements
- EPCIS Version
- v@Model.TechnicalRequirements.EpcisVersion
- Data Format
XML- Integration Method
- API and File Upload
- Barcode Type
- DataMatrix (GS1)
- Required Fields
- GTIN Serial Number Batch/Lot Expiry Date
Product Scope
- Imported pharmaceutical products (Phase 1)
- Locally manufactured medicines (Phase 2)
- Over-the-counter medicines (Phase 3)
- Controlled substances
Key Deadlines
Regulatory Framework Publication
Nov 01, 2025
All manufacturers, warehouses, pharmacies must prepare for compliance
Phase 1 - Imported Medicines
Feb 01, 2026
Imported/international pharmaceutical products - mandatory compliance
Phase 2 - Local Production
Aug 01, 2026
Locally produced or packed pharmaceutical products - mandatory compliance
Phase 3 - OTC Extension
Dec 31, 2026
Aggregation requirements extended to include OTC drugs
Notes
Egypt's EPTTS is inspired by Turkey's successful ITS system. 91% of Egypt's pharmaceutical market is locally manufactured. System goal: end-to-end traceability and product authentication. Phased rollout expected over 3-5 years. Draft guidelines issued by EDA.
Last updated: December 25, 2024